A microfluidic printhead for printing photo-cross linkable hydrogels

对器官修复和移植的需求，以及现有捐赠者的短缺，使得临床需要制定创新的治疗战略，以长期修复和再生受伤或患病的组织和器官。3D打印是一种通过将材料逐层沉积到计算机控制的构建平台上来构建3D对象的过程。生物打印结合了3D打印技术、细胞生物学和材料科学，通过将构建平台与能够沉积生物墨水的设备相结合。生物打印技术适用于广泛的生物材料(如合成和天然聚合物、血液衍生蛋白和脱细胞细胞外基质(ECM))，适应各种细胞来源的生长和增殖，包括干细胞和体细胞。AspectBiosSystems专有的Lab-on-PrinterTM技术利用同轴聚焦的概念，逐层沉积细胞-生物纤维，形成3D组织状结构。Aspects生物系统公司正计划扩展他们的生物墨水库，以包括明胶、甲基丙烯酰基(GelMA)和聚乙二醇二丙烯酸酯(PEGDA)等可光交联材料。Lab-on-a-PrinterTM技术与一系列低粘度和中等粘度的生物油墨兼容，由于结合了良好的机械性能和生物活性和细胞含量与支架成分的高比率，这些油墨特别适合促进组织功能。使用这些材料可以显着提高印刷分辨率，从而更好地控制所制备的支架的微观和宏观结构。该工程项目的总体目标是对目前的打印头墨盒进行改进，以打印可照片交联的明胶，使其成为组织工程领域中广泛使用的生物材料。我们将进行一项系统的表征研究，以制定一种用于制造光交联型水凝胶构建物的协议。细胞将被加载到所制造的构建物中，以评估该过程的生物相容性。

The demand for organ repair and transplantation, and a shortage of available donors necessitates the clinicalneed to develop innovative treatment strategies for long-term repair and regeneration of injured or diseasedtissues and organs. 3D printing is a process used to construct 3D objects by relying on the layer-by-layerdeposition of materials onto a computer-controlled build platform. Bioprinting combines 3D printingtechnology, cell biology, and materials science, by coupling the build platform with a device that enables thedeposition of bioinks. Bioprinting technology is adaptive to a wide range of biomaterials (i.e., synthetic andnatural polymers, blood-derived proteins, and de-cellularized extracellular matrix (ECM)), accommodating thegrowth and proliferation of various cell sources, including stem cells and somatic cells. Aspect Biosystems'proprietary Lab-on-PrinterTM technology utilizes the concept of coaxial-flow focusing to deposit cell-ladenbiological fibers layer-by-layer and form 3D tissue-like constructs. Aspect Biosystems is planning to extendtheir Bioink library to include photo-crosslinkable materials including gelatin methacryloyl (GelMA) andpolyethylene glycol diacrylate (PEGDA). Lab-on- a-PrinterTM technology is compatible with a range of lowand medium viscosity Bioinks that are particularly well suited to promoting tissue function due to acombination of favorable mechanical properties and high ratios of bioactive and cellular content to scaffoldcomponents. Using these materials can significantly improve the printing resolution which will lead to bettercontrol on the micro- and macrostructure of the fabricated scaffolds. The overarching goals of this Engageproject are to modify the current printhead cartridges to print photo-crosslinkable gelatin as a widely usedbiomaterial in the tissue engineering community. We will perform a systematic characterization study todevelop a protocol for the fabrication of photo-crosslinkable hydrogel constructs. Cells will be loaded in thefabricated constructs to evaluate the biocompatibility of the process.